Compare Huntington Ingalls Industries Inc (HII) vs Tenet Healthcare Corporation (THC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Huntington Ingalls Industries Inc vs Tenet Healthcare Corporation — how do they compare? Huntington Ingalls Industries Inc trades at $328 (market cap $12.92B), while Tenet Healthcare Corporation trades at $259.45 (market cap $20.89B). The key difference: Tenet Healthcare Corporation is the larger of the two by market cap, and Huntington Ingalls Industries Inc pays a 1.68% dividend while Tenet Healthcare Corporation pays none. Which is the better fit depends on your goals.
| HII | THC | |
|---|---|---|
Market Cap | $12.92B | $20.89B |
Sector | Technology | Health |
52-Week High | $453.73 | $262.63 |
52-Week Low | $265.40 | $161.37 |
Enterprise Value | $15.84B | $31.97B |
Dividend Yield | 1.68% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HII trades at $324.48, up 0.85% on the day, with a bullish technical signal driven by moving averages and recent contract wins. The company reported strong Q2 2026 results, beating EPS estimates with $5.27 versus $3.79 expected, and revenue growth of 10.9%. Key developments include a $900 million robotics partnership and new submarine contracts, supporting a positive outlook.
The stock offers upside to the consensus price target of $359.67, with 44% of analysts rating it Buy. Risks include execution challenges in shipbuilding and political headwinds. Fundamentals are solid with a P/E of 19.7 and ROE of 12.97%, but overbought RSI levels near 85.92 suggest near-term caution.
Tenet Healthcare (THC) trades at $262.13, up 2.14% with strong technical momentum and bullish analyst sentiment. The stock shows robust fundamentals with Q2 2026 EPS beating estimates at $6.12 versus $4.26 expected, while valuation metrics remain attractive with P/E of 10.05 and EV/EBITDA of 5.74. Recent institutional buying and positive earnings revisions support the upward trend.
Outlook remains positive with consensus price target of $281.44 offering 7.4% upside potential. Key risks include healthcare policy headwinds and competitive pressures, but strong ambulatory growth and expense management provide fundamental support. The stock presents a compelling value-growth combination for investors seeking healthcare exposure.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Huntington Ingalls Industries Inc
Huntington Ingalls is the largest military shipbuilder in the U.S. and a provider of professional services to government and industry partners, specializing in nuclear-powered submarines and aircraft carriers.
Read more on HII →About Tenet Healthcare Corporation
Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.
Read more on THC →
